Management of Rectal Abscesses with Antibiotics

Indications for Antibiotic Therapy

The American College of Surgeons recommends antibiotic therapy for rectal abscesses with systemic signs of infection, such as fever, tachycardia, hypotension, or sepsis, in immunocompetent patients 2, 1
The World Journal of Emergency Surgery suggests that antibiotic therapy is indicated for immunocompromised patients, such as those with diabetes, HIV, chronic steroid use, or chemotherapy 2, 1
The Praxis Medical Insights guideline recommends antibiotic therapy for extensive cellulitis extending beyond the abscess borders or incomplete source control after drainage 2, 1

The Praxis Medical Insights guideline recommends amoxicillin-clavulanate 875/125 mg orally every 12 hours for 7 days as the first-line oral regimen for rectal abscesses, providing broad-spectrum coverage against Gram-positive, Gram-negative, and anaerobic bacteria 1
The World Journal of Emergency Surgery suggests alternative oral regimens, such as ciprofloxacin 500 mg orally every 12 hours plus metronidazole 500 mg orally every 12 hours, or trimethoprim-sulfamethoxazole 1 double-strength tablet orally every 12 hours 1
For parenteral therapy, the Praxis Medical Insights guideline recommends ampicillin-sulbactam 3 g IV every 6 hours, clindamycin 600 mg IV every 8 hours plus gentamicin 5 mg/kg IV daily, or piperacillin-tazobactam 4 g/0.5 g IV every 6 hours 1, 4

The World Journal of Emergency Surgery recommends a duration of therapy of 4 days if source control is adequate in immunocompetent, non-critically ill patients 4
The guideline suggests a duration of therapy of up to 7 days in immunocompromised or critically ill patients based on clinical response and inflammatory markers 5, 4

The World Journal of Emergency Surgery emphasizes the importance of broad-spectrum coverage targeting the polymicrobial nature of rectal abscesses, including Gram-positive, Gram-negative, and anaerobic bacteria 2, 1, 3
The Praxis Medical Insights guideline recommends considering obtaining culture from drained pus in high-risk patients or those with risk factors for multidrug-resistant organisms 1, 3